A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new ...

LOS ANGELES, May 15 (Xinhua) -- In a groundbreaking medical milestone, U.S. researchers have successfully developed and delivered a personalized gene-editing therapy to treat an infant suffering ...

Gene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has ...

A research team has developed and safely delivered a personalized gene editing therapy to treat ... six months and marks the first time the technology has been successfully deployed to treat ...

Baby KJ Muldoon, the first patient to successfully receive personalized CRISPR gene editing therapy has returned home after ...

In a groundbreaking medical achievement, an infant from Pennsylvania, referred to as KJ, has become the first person to successfully receive a personalized CRISPR gene editing therapy. The ...

An attentive doctor at the University of Pennsylvania ... All this is possible because KJ is the first-ever recipient of a gene therapy designed to treat only a single person.

K. J.—now 9 and a half months old—has received three doses of the therapy and has shown no adverse effects. He’s the first person known to receive a tailor-made gene-editing treatment.

A nine-month-old baby has become the first person ever to be successfully treated with personalized gene editing therapy. Researchers corrected a specific gene mutation in baby KJ Muldoon‘s ...

A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive ... these gene and cell therapies,” says Arkasubhra Ghosh, who studies gene therapy ...

The process, from diagnosis to treatment, took only six months and marks the first time the technology has been successfully deployed ... Medicine at the University of Pennsylvania (Penn) developed ...